Textron Aviation expands aircraft service capabilities with new facility at Essendon Fields airport
Textron Aviation is expanding its presence in Australia with the construction of a new aircraft service facility at Essendon Fields Airport in Melbourne. This strategic ... Read More
Adore Beauty partners with tutch to power endless aisle capabilities for retail expansion
Adore Beauty Group Ltd. (ASX: ABY), Australia’s premier online beauty retailer, has announced a strategic partnership with tutch, a Microsoft-backed in-store digital platform, to power ... Read More
Bushfires ravage Victoria: Communities urged to evacuate amid escalating crisis
Victoria is grappling with a severe bushfire crisis, with hundreds of residents forced to evacuate as uncontrollable fires ravage large areas of the state. The ... Read More
Australia stunned as PM labels synagogue arson a terrorist attack
Australia is grappling with the aftermath of a suspected arson attack targeting the Adass Israel Synagogue in Melbourne, an incident that Prime Minister Anthony Albanese ... Read More
TZ Limited announces acquisition of Keyvision to boost proptech capabilities
TZ Limited, a leader in smart locker solutions, has announced a strategic acquisition aimed at expanding its proptech capabilities. The company entered a Heads of ... Read More
Noble Helium secures multi-million-dollar funding—what does it mean for investors?
Noble Helium Limited (ASX) has entered into an At-The-Market (ATM) subscription agreement with Dolphin Corporate Investments (DCI), enabling the company to access up to A$2 ... Read More
InhaleRx secures A$38.5m deal to accelerate pain and mental health breakthroughs
Melbourne-based healthcare innovator InhaleRx Limited (ASX: IRX) has secured a substantial funding deal worth up to AUD 38.5 million, aiming to revolutionize the treatment of ... Read More
Dubber Corporation launches A$25m equity raising to secure growth ambitions
In a significant financial move, Dubber Corporation Limited has announced a A$25 million equity raising, fully underwritten to secure the company's growth trajectory and fuel ... Read More
Neuren Pharmaceuticals advances NNZ-2591 for Phelan-McDermid syndrome to Phase 3 clinical trial
Neuren Pharmaceuticals has secured approval from the United States Food and Drug Administration (FDA) to progress into the first-ever pivotal Phase 3 clinical trial of ... Read More
Immuron Limited reveals key findings from NMRC study, eyes future collaboration with U.S. DoD
Immuron Limited has announced the results of a Campylobacter human infection model study conducted by the U.S. Naval Medical Research Command (NMRC). The Melbourne-based biopharmaceutical ... Read More